Login

The Schneiders sold promissory notes to RBC Dominion Securities Corp and Highland Capital Management through their agent Glen Rauch. 00:10:00

Share On Facebook Share On Twitter

Mussa Hadi. CEO at Highland Capital Management, L.P..

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ryan Simpson: My Journey to Becoming a Financial Planner | Ryan Simpson - Associate Financial Planner of Syverson Strege
00:10:00
Exclusive Interview with Anne Richards: Insights from PLSA Investment Conference 2018
00:10:00
Steadfast Leadership in Turbulent Times: Gerard O'Reilly's Strategies for Long-Term Client Focus at Dimensional Fund Advisors
00:10:00
Generac CEO Discusses Generator Demand Amidst Rising Natural Disasters | Aaron Jagdfeld - CEO of Generac
00:10:00
Identity Security: The Foundation for a Secure Enterprise|BarakKaufman,Senior Director, Product, SailPoint
00:10:00
Step into the world of DFNN with Chris Tiu and learn more about the IT company | Ramon C. Garcia Jr, CEO, DFNN IncDFNN:PHS
00:00:00
Sarah J. Chalmers, M.D. Critical Care Specialist, Mayo Clinic / Ask Mayo Clinic: Cystic Fibrosis
00:10:00
Future Predictions and Investment Strategies in Energy Transition: Insights from Pacific Road Capital
00:10:00
Tim Levy, Managing Director of Family Zone Cyber Safety (ASX:FZO), discusses insights and updates at the TechKnow Invest Roadshow.
00:10:00
Emerging Opportunities in Gold and Base Metals: Tyranno Resources at One-to-One Mining Conference
00:10:00
Exploring Opportunities in Uranium and Gold Mining: Insights from Two Key Companies
00:10:00
Finder Energy's CEO Damon Neaves on Transformative Acquisition and Fast-Tracked Development in Timor-Leste | Damon Neaves, CEO, Finder Energy Holdings Ltd.

© 2026 Nehu